| Literature DB >> 34154636 |
Karin Gallandat1, Aurélie Jeandron2, Ian Ross2, Jaime Mufitini Saidi3, Baron Bashige Rumedeka3, Vercus Lumami Kapepula4, Simon Cousens5, Elizabeth Allen6, Amy MacDougall6, Oliver Cumming2.
Abstract
INTRODUCTION: Diarrhoeal disease remains a leading cause of mortality and morbidity worldwide. Cholera alone is estimated to cause 95,000 deaths per year, most of which occur in endemic settings with inadequate water access. Whilst a global strategy to eliminate cholera by 2030 calls for investment in improved drinking water services, there is limited rigorous evidence for the impact of improved water supply on endemic cholera transmission in low-income urban settings. Our protocol is designed to deliver a pragmatic health impact evaluation of a large-scale water supply intervention in Uvira (Democratic Republic of the Congo), a cholera transmission hotspot. METHODS/Entities:
Keywords: Cholera; Diarrhoea; Infrastructure; Stepped-wedge cluster randomised trial; WASH; Water supply
Mesh:
Year: 2021 PMID: 34154636 PMCID: PMC8215491 DOI: 10.1186/s13063-021-05249-x
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.728
Fig. 3Conceptual framework for the Uvira trial
Key cluster characteristics
| Cluster # | Estimated population (March 2018) | Area [km2] | *Mean # suspected cholera cases per month | *Mean monthly incidence per 1000 | Existing pipe length [m] | Pipe length to rehabilitate [m] | Length of new pipes to install [m] | # existing household connections | # provisionally planned new household connections | Number of planned new community taps | Allocation sequence |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 4291 | 2.02 | 1.9 | 0.4 | 2152 | 57 | 2628 | 16 | 66 | 6 | 15 |
| 2 | 4990 | 0.76 | 6.0 | 1.2 | 1578 | 1658 | 1792 | 89 | 25 | 3 | 16 |
| 3 | 11,183 | 0.87 | 6.4 | 0.6 | 5574 | 1266 | 1864 | 171 | 25 | 7 | 10 |
| 4 | 7328 | 1.02 | 5.4 | 0.7 | 2347 | 0 | 3398 | 25 | 100 | 5 | 12 |
| 5 | 13,649 | 1.27 | 4.4 | 0.3 | 2786 | 797 | 4177 | 19 | 205 | 4 | 9 |
| 6 | 8389 | 0.48 | 5.8 | 0.7 | 1730 | 499 | 2328 | 43 | 82 | 6 | 13 |
| 7 | 7480 | 0.37 | 2.0 | 0.3 | 4525 | 367 | 1065 | 152 | 26 | 2 | 8 |
| 8 | 15,455 | 0.43 | 4.8 | 0.3 | 2961 | 1097 | 1793 | 199 | 25 | 5 | 7 |
| 9 | 3994 | 0.36 | 9.4 | 2.4 | 3848 | 189 | 2446 | 183 | 25 | 8 | 11 |
| 10 | 14,175 | 0.59 | 7.1 | 0.5 | 8901 | 692 | 1520 | 525 | 25 | 7 | 1 |
| 11 | 56,106 | 1.70 | 14.5 | 0.3 | 8775 | 1599 | 2401 | 633 | 254 | 16 | 5 |
| 12 | 12,462 | 0.99 | 3.0 | 0.2 | 2292 | 1455 | 1844 | 22 | 193 | 1 | 14 |
| 13 | 50,764 | 2.75 | 10.4 | 0.2 | 17,781 | 1666 | 1266 | 1384 | 24 | 11 | 4 |
| 14 | 16,175 | 0.55 | 6.7 | 0.4 | 907 | 0 | 2549 | 35 | 220 | 5 | 3 |
| 15 | 15,183 | 0.81 | 7.2 | 0.4 | 4091 | 135 | 2420 | 161 | 62 | 9 | 2 |
| 16 | 19,338 | 1.98 | 10.6 | 0.6 | 1788 | 2061 | 2874 | 28 | 318 | 20 | 6 |
| 1.06 | 6.6 | 0.4** | 72,033 | 13,538 | 36,363 | 3685 | 1675 | 7.2 | – | ||
| Minimum | 3994 | 0.36 | 1.9 | 0.2 | 907 | 0 | 1065 | 16 | 25 | 1 | – |
| Maximum | 56,106 | 2.75 | 14.5 | 2.4 | 17,781 | 2061 | 4177 | 1384 | 318 | 20 | – |
*Based on CTC admissions between January 1, 2009, and March 31, 2018, and population in March 2018
**Mean weighted by cluster population size
Fig. 1Map of Uvira with the definition of clusters and groups: South (blue, n = 6) and North (pink, n = 10)
Fig. 2Trial diagram, inspired by [46]
| # | Item | Description |
| 1 | Primary Registry and Trial Identifying Number | |
| 2 | Date of Registration in Primary Registry | 10th October 2016 |
| 3 | Secondary Identifying Numbers | LSHTM Ethics Review Board protocols #8913, #10603 |
| 4 | Source(s) of Monetary or Material Support | French Agency for Development (AFD) Veolia Foundation (VF) |
| 5 | Primary Sponsor | London School of Hygiene and Tropical Medicine (LSHTM) |
| 6 | Secondary Sponsor(s) | None |
| 7 | Contact for Public Queries | Karin Gallandat, Principal Investigator, karin.gallandat@lshtm.ac.uk Keppel St, London, WC1E 7HT, UK + 44 20 76 36 86 36 |
| 8 | Contact for Scientific Queries | |
| 9 | Public Title | Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo |
| 10 | Scientific Title | The impact of improved water supply on cholera and diarrhoeal diseases in Uvira, Democratic Republic of the Congo: a pragmatic stepped-wedge cluster randomised trial and economic evaluation |
| 11 | Country of Recruitment | Democratic Republic of the Congo |
| 12 | Health Condition(s) or Problem(s) Studied | Cholera, diarrhoeal disease |
| 13 | Intervention | |
| 14 | Key Inclusion and Exclusion Criteria | |
| 15 | Study Type | Interventional; stepped-wedge cluster randomised trial |
| 16 | Date of First Enrolment | 10th October 2016 |
| 17 | Sample Size | Planned enrolment: 5000 Enrolment to date: 4280 |
| 18 | Recruitment Status | Recruiting |
| 19 | Primary Outcome(s) | (1) monthly incidence of suspected cholera cases, as measured by the number of CTC admissions attributed to each cluster; (2) monthly incidence of confirmed cholera cases, based on rapid detection test (RDT) results for consenting patients |
| 20 | Key Secondary Outcomes | None |
| 21 | Ethics Review | Approved. |
| 22 | Completion Date | Expected 27th September 2021 |
| 23 | Summary Results | Not available |
| 24 | IPD Sharing Statement | No IPD sharing |